Adult respiratory physician
Member since 01/02/2011
Professor Peter Wark is a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and a conjoint Professor with the University of Newcastle. In addition he is co-director of the priority research centre for asthma and respiratory disease and a member of the Vaccines Immunology Viruses and Asthma research group at the Hunter Medical Research Institute. He has been a member of the Thoracic Society of Australia and New Zealand (TSANZ) executive board since and chairman of the clinical care and resources subcommittee since 2011. His research interests are in the area of infection and the impact this has on inflammatory airways disease, with a particular interest in viral respiratory infections. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. He is the Centre Director for the John Hunter Adult Cystic Fibrosis clinic and chairperson for the Hunter New England Local Hospital network respiratory stream.
Statement of Interest
I am a member of the Thoracic Society of Australia and New Zealand (TSANZ). I have consulted for AstraZeneca, GlaxoSmithKline, Boehringer-Ingelheim and Sanofi-Roche. I have previously received funding from AstraZeneca and GlaxoSmithKline for speaking engagements. I have received funding in the form of investigation grants from GlaxoSmithKline. I have been an advisory board member for GlaxoSmithKline, AstraZeneca, Boehringer-Ingelheim and Vertex.